[go: up one dir, main page]

SE8305667L - ADENOCARCIN-RELATED NEW ANTIGENA DETERMINANTS AND ANTIBODIES SPECIFIC TO THESE, PROCEDURE FOR THEIR PREPARATION AND REAGENT SYSTEM THEREOF - Google Patents

ADENOCARCIN-RELATED NEW ANTIGENA DETERMINANTS AND ANTIBODIES SPECIFIC TO THESE, PROCEDURE FOR THEIR PREPARATION AND REAGENT SYSTEM THEREOF

Info

Publication number
SE8305667L
SE8305667L SE8305667A SE8305667A SE8305667L SE 8305667 L SE8305667 L SE 8305667L SE 8305667 A SE8305667 A SE 8305667A SE 8305667 A SE8305667 A SE 8305667A SE 8305667 L SE8305667 L SE 8305667L
Authority
SE
Sweden
Prior art keywords
determinants
antigena
adenocarcin
procedure
preparation
Prior art date
Application number
SE8305667A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE8305667D0 (en
Inventor
A Bartorelli
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of SE8305667D0 publication Critical patent/SE8305667D0/en
Publication of SE8305667L publication Critical patent/SE8305667L/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A method suitable for the diagnosis of human adenocarcinomas is described. In the method, antigenic material which is related to adenocarcinomas is determined in a sample which is taken from a human patient. The material in the sample is determined by using (a) anti-K antibodies or (b) anti-P<k> antibodies, using (a') exclusively those antigenic determinants K which are specific for adenocarcinomas, or (b') those antigenic determinants P<k> which with the K determinants are specific for adenocarcinomas.
SE8305667A 1983-06-23 1983-10-14 ADENOCARCIN-RELATED NEW ANTIGENA DETERMINANTS AND ANTIBODIES SPECIFIC TO THESE, PROCEDURE FOR THEIR PREPARATION AND REAGENT SYSTEM THEREOF SE8305667L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838317022A GB8317022D0 (en) 1983-06-23 1983-06-23 Adenocarcinoma related new antigenic determinants

Publications (2)

Publication Number Publication Date
SE8305667D0 SE8305667D0 (en) 1983-10-14
SE8305667L true SE8305667L (en) 1984-12-24

Family

ID=10544654

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8305667A SE8305667L (en) 1983-06-23 1983-10-14 ADENOCARCIN-RELATED NEW ANTIGENA DETERMINANTS AND ANTIBODIES SPECIFIC TO THESE, PROCEDURE FOR THEIR PREPARATION AND REAGENT SYSTEM THEREOF

Country Status (13)

Country Link
JP (1) JPS6018765A (en)
AU (1) AU2017183A (en)
BE (1) BE899484A (en)
DE (1) DE3337465A1 (en)
DK (1) DK476083A (en)
FI (1) FI833742A (en)
FR (1) FR2548901A1 (en)
GB (1) GB8317022D0 (en)
IT (1) IT1194429B (en)
NL (1) NL8303571A (en)
NO (1) NO833756L (en)
SE (1) SE8305667L (en)
ZA (1) ZA837673B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2589630B2 (en) * 1992-06-12 1997-03-12 ゼニヤ海洋サービス株式会社 Water control device for sabo dam

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086217A (en) * 1976-03-03 1978-04-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US4145336A (en) * 1976-04-30 1979-03-20 Scripps Clinic And Research Foundation Carcinoembryonic antigen isomer
US4315851A (en) * 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
EP0044167A3 (en) * 1980-07-14 1982-04-21 The Regents Of The University Of California Antibody targeted cytotoxic agent
EP0072902B1 (en) * 1981-08-21 1985-04-24 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Method for the determination of carcinoembryonic antigen (cea) and suitable antibody solution for the determination
DE3230299A1 (en) * 1982-08-14 1984-02-16 Hoechst Ag, 6230 Frankfurt CARCINOEMBRYONALES ANTIGEN, METHOD FOR ITS INSULATION AND ITS USE

Also Published As

Publication number Publication date
AU2017183A (en) 1985-01-03
FR2548901A1 (en) 1985-01-18
JPS6018765A (en) 1985-01-30
GB8317022D0 (en) 1983-07-27
IT1194429B (en) 1988-09-22
NL8303571A (en) 1985-01-16
BE899484A (en) 1984-10-22
SE8305667D0 (en) 1983-10-14
ZA837673B (en) 1984-08-29
DE3337465A1 (en) 1985-01-03
FI833742A0 (en) 1983-10-14
NO833756L (en) 1984-12-27
IT8323351A0 (en) 1983-10-19
FI833742A (en) 1984-12-24
DK476083D0 (en) 1983-10-14
DK476083A (en) 1984-12-24

Similar Documents

Publication Publication Date Title
NO880866D0 (en) APPARATUS FOR SEPARATION OF BLOOD INGREDIENTS.
AR243931A1 (en) Purified antigen, set of reagents for detecting anti-hiv-2 antibodies in a biological fluid that contains these antigens, antibodies, hybridomas and the procedures involved.
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
MX7563E (en) PROCEDURE FOR PREPARING AN IMMUNOGEN COMPLEX CONTAINING ANTIGENIC PROTEINS AND PEPTIDES
DE3750342D1 (en) Human gamma interferon-specific receptor protein, antibodies against this protein, methods for producing this protein and antibody and compositions containing this protein and antibody.
PT94813A (en) Process for the preparation of EPO peptides of erythropoietin and of anti-antibodies against them
IL68941A0 (en) Method for immobilizing biological materials,composite materials produced thereby and their use
DE2963977D1 (en) Antigen preparation, process for producing it and pharmacological or dental preparations containing the antigen preparation or antibodies thereto
AR240990A1 (en) PROCEDURE FOR THE SEPARATION OF MOLECULES OF BIOLOGICAL INTEREST, FROM A MIXTURE THAT CONTAINS THEM. &#34;
NO873495D0 (en) MONOCLONAL ANTIBODIES AND PEPTIDES SUITABLE FOR TREATMENT AND DIAGNOSIS OF HIV INFECTIONS.
IT8222140A0 (en) PROCEDURE WITHOUT CENTRIFUGATION FOR IMMUNOLOGICAL TESTING OF MATERIALS.
DK304087A (en) HUMANT MONOCLONAL ANTIBODY AGAINST LUMPHADENOPATIA-ASSOCIATED VIRUS
OA08485A (en) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
NO870476D0 (en) PROCEDURE FOR THE PREPARATION OF CROSS PROTECTIVE HUMAN MONOCLONAL ANTIBODY PREPARATIONS.
DK163062C (en) ANTIGEN, IMMUNOGENE, PROTEIN CONTAINING VACCINE AGAINST COCCIDIOSE
DK172686A (en) ANTIGEN DERIVED FROM HUMAN TISSUE, PROCEDURE FOR USING THE ANTIGEN TO MAKE MONOCLONAL ANTIBODIES FOR DIAGNOSIS AND TREATMENT OF CANCER, PROCEDURE FOR DETECTION OF CANCER, AND OTHER
SE8305667L (en) ADENOCARCIN-RELATED NEW ANTIGENA DETERMINANTS AND ANTIBODIES SPECIFIC TO THESE, PROCEDURE FOR THEIR PREPARATION AND REAGENT SYSTEM THEREOF
KR890700683A (en) Methods for searching for antibodies against human immunodeficiency virus
SE8205891D0 (en) ALFA-L ANTIBODY AND SET FOR PRODUCING THEREOF
EP0307476A4 (en) Bilirubin antigen, monoclonal antibody therefor, process for their preparation, and their use
EP0269677A4 (en) TEST PROCEDURE AND ANTIBODIES FOR N-MYC PROTEINS.
DK147194C (en) DEVICE FOR MEDICAL TREATMENT, EXAMINATION OR TESTING
FR2571146B1 (en) CARCINO-FETAL ANTIGENS OF HUMAN PANCREAS AND A PURIFICATION PROCESS, ANTISERUM AGAINST SUCH ANTIGENS AND ITS PREPARATION METHOD AND DIAGNOSTIC COMPOSITIONS CONTAINING THEM
NO880835L (en) PROCEDURE AND APPARATUS FOR QUALITATIVE AND / OR QUANTITATIVE ANALYSIS OF ANTIGENS, ANTIBODIES, MICROORGANISMS OR OTHER CELLS.
ES2059539T3 (en) METHOD FOR THE PREVENTION OF GRAFT DISEASE AGAINST THE GUEST.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8305667-1

Effective date: 19870501